Technical Analysis for SVRA - Savara, Inc.

Grade Last Price % Change Price Change
grade C 7.86 -2.24% -0.18
SVRA closed down 2.24 percent on Friday, March 22, 2019, on 1.49 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Down
See historical SVRA trend table...

Date Alert Name Type % Chg
Mar 22 20 DMA Support Bullish 0.00%
Mar 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 21 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.24%
Mar 21 Narrow Range Bar Range Contraction -2.24%
Mar 21 NR7 Range Contraction -2.24%
Mar 21 Inside Day Range Contraction -2.24%
Mar 21 Wide Bands Range Expansion -2.24%
Mar 20 Wide Bands Range Expansion -1.75%
Mar 19 Inside Day Range Contraction -2.12%
Mar 19 Wide Bands Range Expansion -2.12%

Older signals for SVRA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Savara Inc., formerly Mast Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the development and commercialization of novel therapies for the treatment of patients with rare respiratory diseases. Its pipeline includes AeroVanc, Molgradex and AIR001. AeroVanc is an inhaled formulation of vancomycin, which the Company is developing for the treatment of persistent methicillin-resistant Staphylococcus aureus, lung infection in cystic fibrosis patients. Molgradex is an inhaled formulation of recombinant human granulocyte-macrophage colony-stimulating factor. It is developing Molgradex for the treatment of autoimmune pulmonary alveolar proteinosis, a rare lung disease. AIR001 is a sodium nitrite solution for inhalation via nebulization. AIR001 is in Phase II clinical development for the treatment of heart failure with preserved ejection fraction, also known as diastolic heart failure or heart failure with preserved systolic function.
Medicine Medical Specialties Pharmaceutical Cystic Fibrosis Heart Failure Staphylococcus Aureus Heart Diseases Treatment Of Heart Failure Total Synthesis
Is SVRA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 14.06
52 Week Low 6.21
Average Volume 120,566
200-Day Moving Average 9.6334
50-Day Moving Average 7.4882
20-Day Moving Average 7.7435
10-Day Moving Average 8.152
Average True Range 0.4395
ADX 22.53
+DI 19.4239
-DI 19.3621
Chandelier Exit (Long, 3 ATRs ) 7.3515
Chandelier Exit (Short, 3 ATRs ) 7.8985
Upper Bollinger Band 8.8209
Lower Bollinger Band 6.6661
Percent B (%b) 0.55
BandWidth 27.82721
MACD Line 0.2048
MACD Signal Line 0.2046
MACD Histogram 0.0002
Fundamentals Value
Market Cap 190.24 Million
Num Shares 24.2 Million
EPS -3.50
Price-to-Earnings (P/E) Ratio -2.25
Price-to-Sales 526.42
Price-to-Book 2.64
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.48
Resistance 3 (R3) 8.47 8.27 8.37
Resistance 2 (R2) 8.27 8.11 8.27 8.34
Resistance 1 (R1) 8.06 8.01 7.96 8.07 8.30
Pivot Point 7.86 7.86 7.81 7.86 7.86
Support 1 (S1) 7.65 7.70 7.55 7.66 7.42
Support 2 (S2) 7.45 7.60 7.45 7.38
Support 3 (S3) 7.24 7.45 7.35
Support 4 (S4) 7.25